Home/Publication/HongShan, Fosun Health Separately Back Cancer Treatment Plays
HongShan, Fosun Health Separately Back Cancer Treatment Plays 

25 Aug 2025

US$ 20.00

HongShan Capital Group, Trinity Innovation Fund and Apricot Capital have participated in the series A financing ......

Price / article: US$20.00
OR existing subscriber
Related Publications

Subscribers’ Weekly for the week ending 29 Aug 2025...

Listen to Australia/New Zealand News (Subscribers' Weekly 29 Aug 2025)...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.